切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (03) : 301 -305. doi: 10.3877/cma.j.issn.1674-6902.2019.03.007

所属专题: 文献

论著

老年COPD合并支气管扩张的危险因素分析
刘斌1,(), 周瑞清1, 邢青峰1   
  1. 1. 236000 阜阳,安徽省阜阳市人民医院呼吸与危重症医学科
  • 收稿日期:2019-02-11 出版日期:2019-06-20
  • 通信作者: 刘斌
  • 基金资助:
    安徽省卫生厅课题资助项目(13ZC024)

Analysis of risk factors for elderly patients with chronic obstructive pulmonary disease complicated with bronchiectasis

Bin Liu1,(), Ruiqing Zhou1, Qingfeng Xing1   

  1. 1. Department of Pulmonary and Critical Care Medicine, Fuyang People′s Hospital, Fuyang 236000, China
  • Received:2019-02-11 Published:2019-06-20
  • Corresponding author: Bin Liu
  • About author:
    Corresponding author: Liu Bin, Email:
引用本文:

刘斌, 周瑞清, 邢青峰. 老年COPD合并支气管扩张的危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2019, 12(03): 301-305.

Bin Liu, Ruiqing Zhou, Qingfeng Xing. Analysis of risk factors for elderly patients with chronic obstructive pulmonary disease complicated with bronchiectasis[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(03): 301-305.

目的

探讨老年慢性阻塞性肺疾病(COPD)合并支气管扩张的危险因素。

方法

回顾性分析2015年6月至2018年6月我院收治的153例COPD患者病例资料。按照是否合并支气管扩张,将患者分为单纯COPD组(n=96)和合并支气管扩张组(n=57)。比较两组患者的一般资料、临床症状、血常规指标及红细胞沉降率(ESR)、血气分析检测指标,分析患者痰标本中细菌组成,合并支气管扩张的危险因素。

结果

单纯COPD组与合并支气管扩张组患者性别、年龄、吸烟史、肺结核史及住院时间相比有明显差异(P<0.05);合并支气管扩张患者症状持续时间及伴脓痰症状人数明显高于单纯COPD组(P<0.05);单纯COPD组患者血清中血红蛋白(Hb)水平明显高于合并支气管扩张组患者,C反应蛋白(CRP)及ESR明显低于合并支气管扩张组患者(P<0.05);合并支气管扩张组患者二氧化碳分压(PaCO2)水平明显高于单纯COPD组患者(P<0.05);合并支气管扩张组患者痰涂片铜绿假单胞菌感染例数明显高于单纯COPD组患者(P<0.05);COPD患者中,女性、有肺结核史、痰涂片有铜绿假单胞菌感染、伴脓痰症状、症状持续时间长及住院时间长是合并支气管扩张的危险因素(P<0.05)。

结论

女性、住院时间长、肺结核史、痰涂片铜绿假单胞菌感染、伴脓痰症状、症状持续时间长及住院时间长的COPD患者更易患支气管扩张,是老年COPD患者合并支气管扩张的危险因素。

Objective

To investigate the risk factors for elderly patients with chronic obstructive pulmonary disease (COPD) complicated with bronchiectasis.

Methods

Retrospective analysis was performed on the data of 153 patients with COPD who were admitted to our hospital from June 2015 to June 2018. The patients were divided into a COPD group (n=96) and a combined bronchiectasis group (n=57) according to the presence or absence of bronchiectasis. The general data, clinical symptoms, blood routine indicators and erythrocyte sedimentation rate (ESR), as well as the blood gas analysis indicators of the patients were compared between the two groups. The bacterial composition in the sputum specimens and the influencing factors of bronchiectasis were analyzed.

Results

The gender, age, smoking history, tuberculosis history and hospital stay had statistical differences between the COPD group and the combined bronchiectasis group (P<0.05). The duration of symptoms and the number of patients with purulent symptoms in the combined bronchiectasis group were significantly higher than those of the COPD group (P<0.05). The patients in the COPD group had higher serum levels of hemoglobin (Hb) as well as lower levels of C-reactive protein (CRP), ESR and the partial pressure of carbon dioxide (PaCO2) than those of the combined bronchiectasis group (P<0.05). The incidence of Pseudomonas aeruginosa infection in the sputum smears of the combined bronchiectasis group was higher than that of the COPD group (P<0.05). Therefore, among the elderly patients with COPD, females or the patients who had a tuberculosis history, Pseudomonas aeruginosa infection, purulent sputum symptoms, long duration of symptoms or long hospitalization were easy to suffer from bronchiectasis (P<0.05).

Conclusion

Female, long hospitalization time, history of tuberculosis, pseudomonas aeruginosa infection, purulent sputum symptoms, long duration of symptoms and long hospitalization time are risk factors for bronchiectasis in the elderly patients with COPD.

表1 两组一般资料比较
表2 两组临床症状比较
表3 两组血常规指标及ESR比较(±s)
表4 两组血气分析指标比较(±s)
表5 两组痰标本中细菌组成比较[例(%)]
表6 COPD合并支气管扩张组患者多因素回归分析
1
陈蓉. 慢性阻塞性肺疾病合并肺间质纤维化的临床及病理变化特点分析[J]. 临床合理用药杂志,2016, 9(21): 167-168.
2
Zou SC, Jiang J, Song J. IL-33 induced inflammation exacerbated the development of chronic obstructive pulmonary disease through oxidative stress[J]. Eur Rev Med Pharmacol Sci, 2018, 22(6): 1758-1764.
3
李娟,刘翩,黎晓强,等. 40岁以上人群慢性阻塞性肺疾病患病率及危险因素研究[J]. 重庆医学,2016, 45(3): 396-398.
4
施宇衡,马佳韵,梁丽,等. 支气管扩张症肺功能损害与气道炎症因子表达[J]. 临床肺科杂志,2018, 23(5): 789-793.
5
Gao Y, Guan W, Liu S, et al. Aetiology of bronchiectasis in adults: A systematic literature review[J]. Respirology, 2016, 21(8): 1376-1383.
6
王锋,杨荀,何国庆,等. 支气管扩张合并COPD患者肺功能的改变及危险因素分析[J]. 湖南师范大学学报(医学版), 2018, 15(4): 99-102.
7
Martínezgarcía MÁ,Solercataluña JJ, Donat SY, et al. Factors associated with bronchiectasis in patients with COPD.[J]. Chest, 2011, 140(5): 1130-1137.
8
姜昊,俞万钧,王华英. 支气管扩张症-慢性阻塞性肺疾病重叠综合征研究进展[J]. 临床荟萃,2016, 31(7): 797-799.
9
Kuwano K, Araya J, Hara H, et al. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF)[J]. Respir Investig, 2016, 54(6): 397-406.
10
李思嘉,郭爱敏,赵艳伟. 慢性阻塞性肺疾病患者疾病感知现况及其影响因素分析[J]. 中国护理管理,2017(8): 1112-1116.
11
Du Q, Jin J, Liu X, et al. Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis[J]. Plos One, 2016, 11(3): A101-A101.
12
魏盼,李恋曲,吴鹏,等. 上皮间质转化与哮喘气道重塑的研究进展[J]. 中国药理学通报,2018, v.34(5): 15-18.
13
胡旭,靳开宇,范贤明. 慢性阻塞性肺疾病合并支气管扩张的发病机制、诊断与治疗研究进展[J]. 山东医药,2016, 56(31): 106-108.
14
D′Abrosca F, Garabelli B, Savio G, et al. Comparing airways clearance techniques in chronic obstructive pulmonary disease and bronchiectasis: positive expiratory pressure or temporary positive expiratory pressure? A retrospective study[J]. Braz J Phys Ther, 2017, 21(1): 15-23.
15
金贵明. 慢性阻塞性肺疾病的病理学改变及多层螺旋CT诊断研究进展[J]. 医疗装备,2017, 30(10): 180-181.
16
Grohé C. Obstructive lung disease: chronic progression must be stopped[J]. Dtsch Med Wochenschr, 2016, 141(10): 686.
17
陈勇,刘双,焦瑞. 慢性阻塞性肺疾病合并支气管扩张患者的临床特点分析[J]. 心肺血管病杂志,2016, 35(4): 275-278.
18
Schäfer J, Griese M, Chandrasekaran R, et al. Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis[J]. BMC Pulm Med, 2018, 18(1): 79.
19
王永红,夏远舰,阎锡新,等. 慢性阻塞性肺疾病合并支气管扩张患者临床特点分析[J]. 国际呼吸杂志,2018, 38(19): 1460.
20
张洁,樊惠霞. 老年初治涂阳肺结核合并低白蛋白血症对治疗转归的影响[J]. 吉林医学,2016, 37(9): 2208-2210.
21
王盛美,揭志军. 稳定期COPD患者高碳酸血症治疗及预后的研究进展[J]. 医学综述,2018, 24(3): 522-526.
22
姜思源,张锦. 手术应激后低蛋白血症启因及治疗的最新进展[J]. 中华危重病急救医学,2017, 29(3): 284.
23
Jiang S, Zhang J. Recent advances in the pathogenesis and treatment of hypoproteinemia after surgical stress.[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2017, 29(3): 284.
24
Gojo M K, Prakaschandra R. Acute systemic inflammatory response after cardiac surgery in patients infected with human immunodeficiency virus using clinical and inflammatory markers[J]. African Health Sciences, 2017, 17(3): 719-728.
25
王艳玲. C反应蛋白和血沉联合检测对慢性阻塞性肺疾病并发急性感染的预测价值[J]. 感染、炎症、修复,2016, 17(1): 29-31.
26
张小飞,张彩萍,王耀勇. 频繁住院的慢性阻塞性肺疾病患者进行铜绿假单胞菌监测的状况分析[J]. 实用医学杂志,2016, 32(16): 2771-2772.
27
郭安,汪群智. 社区获得性铜绿假单胞菌感染诱发慢性阻塞性肺疾病急性加重的危险因素[J]. 中华老年医学杂志,2017, 36(8): 864.
28
姚伟梅,程绕,杜倩,等. 铜绿假单胞菌医院感染的调查与耐药性分析[J]. 中华医院感染学杂志,2017, 27(21): 4819-4821, 4841.
29
陈愉生,吴春兰,李鸿茹,等. 铜绿假单胞菌血流感染56例临床分析[J]. 中国感染与化疗杂志,2016, 16(5): 529-535.
30
李希,何芳,李林,等. 慢性阻塞性肺疾病合并支气管扩张症患者预后相关因素研究[J]. 山西医药杂志,2017, 46(8): 945-948.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[7] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要